Neuroendocrine Tumors of Old Patients in the West of France

UnknownOBSERVATIONAL
Enrollment

306

Participants

Timeline

Start Date

December 31, 2018

Primary Completion Date

March 28, 2020

Study Completion Date

March 28, 2020

Conditions
Neuroendocrine Tumors
Trial Locations (1)

29609

CHRU de Brest, Brest

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

University Hospital, Brest

OTHER